12:00 AM
Sep 10, 2012
 |  BC Week In Review  |  Company News  |  Other News

Amarin cardiovascular news

Amarin said the U.S. Patent and Trademark Office (PTO) issued a Notice of Allowance for three patent applications in the company's patent portfolio for Vascepa icosapent ethyl (formerly

Read the full 139 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >